Global Ganja Report

Florida is rapidly shaping up as a test case in whether the term "medical marijuana" necessarily has to include actual herbaceous cannabis. On May 15, the state's  Health Department ordered Quincy-based Trulieve dispensary to stop selling a "whole flower" product—officially intended for use in vaporizers but which can of course also be smoked. Trulieve just last week began sales of product dubbed “Entourage,”—named for the so-called "entourage effect," the synergistic workings of the various compounds in the actual cannabis flower. product meant to be used in the Volcano vaporizer, last week, reports Orlando Weekly. The Health Department's cease-and-desist letter came after local media reports about the sales of Entourage.

Mexico's lower-house Chamber of Deputies on April 28 approved a bill to allowing use, production and distribution of cannabis for medical and scientific purposes. The vote was an overwhelming 371 in favor and seven against with 11 abstentions. The legislation was already approved by the Mexican Senate in December and now goes to the desk of President Enrique Pena Nieto for his signature. The passage follows a national debate on the question in the media and various social forums across the country.

Wisconsin became the latest state to pass a strictly limited semblance of a medical marijuana law on April 18 as the arch-conservative Gov. Scott Walker signed Senate Bill 10, allowing patients to receive cannabidiol (CBD) extract from a physician or pharmacy with a prescription. The law, already passed by both houses of the legislature, takes effect immediately. It passed the Senate with only one dissenting vote, pointing to widespread support for the measure in the Badger State.

The medical marjuana advocacy organization Mamá Cultiva, which has been campaigning on the issue across South America, is criticizing the new measure just passed by Argentina's Senate for failing to legalize personal cultivation. The Senate voted unanimously on March 29 to legalize cannabis oil and other derivatives for medical purposes. Talking Drugs blog reports that the bill is set to become law immediately upon receiving President Mauricio Macri's signature, as it was already passed by the lower-house Chamber of Deputies in November. Under the law, patients must register with a planned national program to be overseen by the Ministry of Health.

The group High NY, "New York's Cannabis Community," hosted an event on "How to Apply Your Skills in the Cannabis Industry" at a Lower Manhattan venue the evening of March 22, featuring speakers with background in the biz from California, Massachusetts and the District of Columbia. Unlike these three polities, New York state has not legalized. But organizers took heart that on that very same day as their meet-up, chronic pain was added to the qualifying conditions under the Empire State's burgeoning if still limited medical marijuana program.

China is to get its first company dedicated to research, development and marketing of medicinal products based on cannabidiol, or CBD. The firm, dubbed XiBiDi Biotechnology Co, is to operate out of Pudong Technology Park, part of the Shanghai Pilot Free-Trade Zone. It will initially offer hemp-derived CBD oil, as well as hemp-based foods and beverages, according to a press release from ChineseInvestors.com, or CIIX. The Chinese character "XiBiDi" is homophonic to "CBD" in English.

A little New York-California cross-fertilization of herbal consciousness took place as Martin Lee, the author of Smoke Signals: A Social History of Marijuana, spoke in Manhattan's East Village the night of Nov. 10 on "The Future of CBD and Medicinal Cannabis." Lee discussed his current work with California-based Project CBD, dedicated to promoting and publicizing research into the medical uses of cannabidiol, and Emerald Pharms, his CBD-oriented dispensary in Hopland, southern Medocino County. The event was hosted by The Alchemist's Kitchen, a New Age-flavored herbal apothecary—or "botanical dispensary"—on East 1st Street. Under New York state's medical marijuana law, the Kitchen recently launched a Bowery Cannabis Club, which specializes in CBD products.

The British government's Medicines & Healthcare Regulatory Agency (MHRA) on Oct. 11 issued a finding that cannabidiol (CBD) has a "restoring, correcting or modifying" effect on "physiological functions." The Independent calls the move "a potential milestone in the campaign to legalise cannabis and bring about evidence-based laws regarding drugs."  The review of CBD, a non-psychoactive cannabinoid increasingly studied for its therapeutic value, was undertaken following discussions with MediPen, a London-based company that seeks to market a CBD vaporizer.